Guangdong Biolight Meditech Future Growth
Future criteria checks 3/6
Guangdong Biolight Meditech is forecast to grow earnings at 108.8% per annum. EPS is expected to grow by 108.9% per annum.
Key information
108.8%
Earnings growth rate
108.9%
EPS growth rate
| Medical Equipment earnings growth | 22.5% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 20 May 2024 |
Recent future growth updates
No updates
Recent updates
Returns On Capital Signal Tricky Times Ahead For Guangdong Biolight Meditech (SZSE:300246)
Jun 07
Why Investors Shouldn't Be Surprised By Guangdong Biolight Meditech Co., Ltd.'s (SZSE:300246) 30% Share Price Plunge
Jun 06There's No Escaping Guangdong Biolight Meditech Co., Ltd.'s (SZSE:300246) Muted Revenues Despite A 31% Share Price Rise
Mar 08Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2024 | 1,116 | -89 | -63 | 168 | N/A |
| 12/31/2023 | 1,194 | -65 | -91 | 129 | N/A |
| 9/30/2023 | 1,267 | 76 | -96 | 120 | N/A |
| 6/30/2023 | 1,291 | 74 | -150 | 72 | N/A |
| 3/31/2023 | 1,236 | 35 | -126 | 70 | N/A |
| 1/1/2023 | 1,184 | 22 | -71 | 141 | N/A |
| 9/30/2022 | 1,176 | 5 | -131 | 89 | N/A |
| 6/30/2022 | 1,142 | 18 | -97 | 108 | N/A |
| 3/31/2022 | 1,140 | 53 | -72 | 113 | N/A |
| 1/1/2022 | 1,091 | 64 | -83 | 81 | N/A |
| 9/30/2021 | 1,078 | 101 | 31 | 159 | N/A |
| 6/30/2021 | 1,126 | 159 | 32 | 146 | N/A |
| 3/31/2021 | 1,416 | 330 | 315 | 385 | N/A |
| 12/31/2020 | 1,396 | 346 | 387 | 456 | N/A |
| 9/30/2020 | 1,318 | 324 | 329 | 386 | N/A |
| 6/30/2020 | 1,219 | 277 | 347 | 404 | N/A |
| 3/31/2020 | 858 | 89 | 86 | 138 | N/A |
| 12/31/2019 | 826 | 65 | 34 | 81 | N/A |
| 9/30/2019 | 826 | 70 | 76 | 125 | N/A |
| 6/30/2019 | 809 | 58 | 12 | 98 | N/A |
| 3/31/2019 | 818 | 61 | -6 | 78 | N/A |
| 12/31/2018 | 813 | 64 | -19 | 81 | N/A |
| 9/30/2018 | 791 | 51 | -46 | 53 | N/A |
| 6/30/2018 | 778 | 53 | 23 | 85 | N/A |
| 3/31/2018 | 739 | 59 | 1 | 73 | N/A |
| 12/31/2017 | 711 | 58 | N/A | 73 | N/A |
| 9/30/2017 | 698 | 72 | N/A | 63 | N/A |
| 6/30/2017 | 649 | 76 | N/A | 48 | N/A |
| 3/31/2017 | 621 | 70 | N/A | 43 | N/A |
| 12/31/2016 | 594 | 67 | N/A | 51 | N/A |
| 9/30/2016 | 541 | 49 | N/A | 65 | N/A |
| 6/30/2016 | 508 | 45 | N/A | 30 | N/A |
| 3/31/2016 | 437 | 31 | N/A | 38 | N/A |
| 12/31/2015 | 381 | 24 | N/A | 28 | N/A |
| 9/30/2015 | 347 | 37 | N/A | 9 | N/A |
| 6/30/2015 | 302 | 27 | N/A | 22 | N/A |
| 3/31/2015 | 302 | 33 | N/A | 25 | N/A |
| 12/31/2014 | 289 | 34 | N/A | 42 | N/A |
| 9/30/2014 | 258 | 25 | N/A | 34 | N/A |
| 6/30/2014 | 249 | 28 | N/A | 25 | N/A |
| 3/31/2014 | 248 | 31 | N/A | 33 | N/A |
| 12/31/2013 | 235 | 29 | N/A | 27 | N/A |
| 9/30/2013 | 232 | 38 | N/A | 31 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300246 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.9%).
Earnings vs Market: 300246 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 300246 is expected to become profitable in the next 3 years.
Revenue vs Market: Insufficient data to determine if 300246's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 300246's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 300246's Return on Equity is forecast to be high in 3 years time